Search Tool Menu
Menu
Close Button
Leadership
  • Marc Stapley
    Chief Executive Officer
    Marc Stapley
    Chief Executive Officer
    Mr. Stapley has deep experience in the genomic diagnostics industry, including significant expertise building and leading complex global operations.
    MORE ABOUT Marc >
  • Bonnie H. Anderson
    Co-founder and Executive Chairwoman
    Bonnie H. Anderson
    Co-founder and Executive Chairwoman
    Her career spans over 40 years in regulated diagnostics and life science markets. She co-founded Veracyte in 2008 and served as Chief Executive Officer and Chairman of the Board until June 1, 2021, when she assumed the role of Executive Chairwoman.
    MORE ABOUT Bonnie >
  • Giulia C. Kennedy, Ph.D.
    Global Chief Scientific Officer and Chief Medical Officer
    Giulia C. Kennedy, Ph.D.
    Global Chief Scientific Officer and Chief Medical Officer
    Giulia C. Kennedy, Ph.D., is Veracyte’s Global Chief Scientific and Medical Officer, overseeing a global team of research and development, medical affairs, data science and clinical affairs professionals to fuel the company’s novel tests and pipeline.
    MORE ABOUT Giulia >
  • Rebecca Chambers
    Executive Vice President and Chief Financial Officer
    Rebecca Chambers
    Executive Vice President and Chief Financial Officer
    Rebecca Chambers has extensive healthcare leadership experience, previously serving as Chief Financial Officer for Outset Medical, a publicly traded medical technology company focused on reducing dialysis cost and complexity.
    MORE ABOUT Rebecca >
  • Tina S. Nova, Ph.D.
    President, CLIA U.S. Business
    Tina S. Nova, Ph.D.
    President, CLIA U.S. Business
    Tina S. Nova, Ph.D., serves as President of Veracyte’s CLIA U.S. Business. In this role, she leads all aspects – market development, product marketing, reimbursement, sales and lab operations – of the company’s broad menu of diagnostic tests that are performed in its laboratories, serving physicians and their patients in the United States.
    MORE ABOUT Tina >
  • Stephane Debono
    Executive Vice President and General Manager, In Vitro Diagnostics (IVD) and EMEA Organizations
    Stephane Debono
    Executive Vice President and General Manager, In Vitro Diagnostics (IVD) and EMEA Organizations
    Stephane Debono is a seasoned executive and entrepreneur who brings more than 25 years of life sciences and healthcare experience to Veracyte.
    MORE ABOUT Stephane >
  • Rob Brainin
    Executive Vice President and Chief Business Officer
    Rob Brainin
    Executive Vice President and Chief Business Officer
    Rob Brainin is a seasoned professional with over 20 years of executive life sciences and healthcare experience, and a proven track record of using emerging technologies and data science to improve healthcare.
    MORE ABOUT Rob >
  • Bill Zondler
    Senior Vice President and Chief Information Officer
    Bill Zondler
    Senior Vice President and Chief Information Officer
    Bill Zondler’s career spans more than 25 years in information technology, including over 20 years in clinical laboratories and the pharmaceutical, medical device, life sciences and biotechnology industries.
    MORE ABOUT Bill >
  • Vincent Fert
    Executive Vice President, Immuno-Oncology and EU Strategic Initiatives
    Vincent Fert
    Executive Vice President, Immuno-Oncology and EU Strategic Initiatives
    Vincent Fert has extensive diagnostic leadership experience, most recently serving as the Founder, Chairman and Chief Executive Officer of HalioDx, an immuno-oncology diagnostics company recently acquired by Veracyte.
    MORE ABOUT Vincent >
  • Morten Frost
    Chief Commercial Officer, In Vitro Diagnostics (IVD)
    Morten Frost
    Chief Commercial Officer, In Vitro Diagnostics (IVD)
    Morten Frost leads sales, marketing, and market access for the company’s diagnostics tests, serving physicians and their patients in global markets, as well as Veracyte’s companion diagnostic development services for biopharmaceutical companies.
    MORE ABOUT Morten >
  • Corinne Danan
    General Manager, Biopharma
    Corinne Danan
    General Manager, Biopharma
    Corinne Danan serves as Veracyte’s General Manager, Biopharma, leading the company’s offerings to biopharmaceutical companies. Ms. Danan brings more than 30 years of executive experience in the pharmaceutical, life sciences and healthcare industries, as well as strong leadership in Commercial Operations, to her role at Veracyte.
    MORE ABOUT Corinne >
  • Fabienne Hermitte, Ph.D.
    Senior Vice President, Global Quality & Regulatory Affairs and Head of Medical Affairs, Immuno-Oncology
    Fabienne Hermitte, Ph.D.
    Senior Vice President, Global Quality & Regulatory Affairs and Head of Medical Affairs, Immuno-Oncology
    Fabienne Hermitte, Ph.D., brings deep expertise in clinical diagnostics to her role at Veracyte. She cofounded HalioDx, an immuno-oncology diagnostics company, in 2015. At HalioDx, she led the Regulatory, Quality, Medical Affairs, Clinical Development and Diagnostic Marketing teams prior to the company’s acquisition by Veracyte in August 2021.
    MORE ABOUT Fabienne >
  • Tracy Morris
    Vice President, Corporate Communications and Investor Relations
    Tracy Morris
    Vice President, Corporate Communications and Investor Relations
    In this role, she works in tandem with the Chief Executive Officer and executive team to communicate the company’s strategic vision and value proposition to investors and other audiences and ensures that the market-leading company’s brand is articulated in product and other communications.
    MORE ABOUT Tracy >
  • Kate Godfrey
    Vice President, Chief Compliance and Privacy Officer
    Kate Godfrey
    Vice President, Chief Compliance and Privacy Officer
    Kate Godfrey joined Veracyte as Chief Compliance and Privacy Officer in November of 2021 and is responsible for the company’s enterprise-wide compliance programs, which manage risks associated with all core business activities, as well as its global privacy program.
    MORE ABOUT Kate >